Lysis of HLA-A*0201–positive tumor cell lines
. | Effector-target ratio . | . | . | . | . | . | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
. | CYP190 . | . | . | CYP239 . | . | . | |||||
Cell line . | 30 . | 10 . | 3 . | 30 . | 10 . | 3 . | |||||
U266 | 31 | 14 | 6 | 38 | 23 | 10 | |||||
36M | 14 | 4 | 0 | 35 | 20 | 10 | |||||
K029 | 30 | 14 | 7 | 45 | 18 | 4 | |||||
IM-9 | 44 | 29 | 12 | 36 | 16 | 4 | |||||
monocytes A2+ | 2 | 0 | 0 | 0 | 0 | 0 |
. | Effector-target ratio . | . | . | . | . | . | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
. | CYP190 . | . | . | CYP239 . | . | . | |||||
Cell line . | 30 . | 10 . | 3 . | 30 . | 10 . | 3 . | |||||
U266 | 31 | 14 | 6 | 38 | 23 | 10 | |||||
36M | 14 | 4 | 0 | 35 | 20 | 10 | |||||
K029 | 30 | 14 | 7 | 45 | 18 | 4 | |||||
IM-9 | 44 | 29 | 12 | 36 | 16 | 4 | |||||
monocytes A2+ | 2 | 0 | 0 | 0 | 0 | 0 |
Lysis of HLA-A*0201—negative control cell lines was consistently less than 10% at the 30:1 effector-target ratio (data not shown). The NK cell target K562 was not lysed (data not shown). Results are representative of at least 2 and as many as 15 experiments. Expression of CYP1B1 in target cells was confirmed by Western blot analysis (Figure 1 and data not shown).